US chemicals company Chemours reported third-quarter 2026 net income of $196 million, up from $46 million a year earlier. Sales increased 3% to $1.54 billion. However, reported profit included $150 million in PFAS-related insurance proceeds. Adjusted net income rose to $31 million, while adjusted EBITDA increased to $200 million, reflecting stronger titanium dioxide pricing and advanced materials demand this quarter.
Chemours Net Profit Jumps to $196 Million
Continue Reading
More coverage on the subjects, companies and places discussed in this article.
